Stocktoria
FATE THERAPEUTICS INC FATE
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2013-10-01
FATE THERAPEUTICS INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 10,116,106 | $33.2M |
| TWO SIGMA INVESTMENTS, LP | 3,466,786 | $4.2M |
| AQR CAPITAL MANAGEMENT LLC | 3,001,521 | $3.6M |
| RENAISSANCE TECHNOLOGIES LLC | 2,974,683 | $3.6M |
| CITADEL ADVISORS LLC | 970,226 | $1.2M |
| Point72 Asset Management, L.P. | 43,119 | $51,743 |
Source: SEC EDGAR filings · CIK 0001434316 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.